Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03336996
Other study ID # Xhechun4
Secondary ID
Status Not yet recruiting
Phase N/A
First received October 26, 2017
Last updated November 6, 2017
Start date March 2018
Est. completion date March 2021

Study information

Verified date October 2017
Source General Hospital of Ningxia Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nowadays, the stem cell therapy is a promising method in treatment of the traumatic nerve fiber injuries. And the clinical use of umbilical cord mesenchymal stem cells has been approved by FDA. However, the results are inconsistent from both human study and animal research, it often difficult to visualize the reconstruction of the motor circuits. A separate application of DTI could not precisely reveal white matter integrity. Combining blood oxygen level-dependent(BOLD)-functional magnetic resonance imaging(fMRI) with diffusion tensor-based tractography (DTT), to detect neural activities in the brain involved in the motor function restore and then using the two seeds method to reconstruct the nerve fibers between these connecting regions. The main aim of this study: i. To characterize and evaluate functional and anatomical changes of nerve fiber injuries after umbilical cord mesenchymal stem cells transplantation with BOLD drived-diffusion tensor imaging(DTI). ii. To determine the therapeutic efficiency of umbilical cord mesenchymal stem cells and also the utility of the integration of BOLD-fMRI and DTI. iii. To correlate the imaging results with the electrophysiology outcomes.


Description:

The stem cell therapy is a promising method in treatment of the traumatic nerve fiber injuries. And the clinical use of umbilical cord mesenchymal stem cells has been approved by FDA. However, the results are inconsistent from both human study and animal research, it often difficult to visualize the reconstruction of the motor circuits. A separate application of DTI could not precisely reveal white matter integrity. Combining BOLD-fMRI with diffusion tensor-based tractography (DTT), to detect neural activities in the brain involved in the motor function restore and then using the two seeds method to reconstruct the nerve fibers between these connecting regions. The main aim of this study: i. To characterize and evaluate functional and anatomical changes of nerve fiber injuries after umbilical cord mesenchymal stem cells transplantation with BOLD drived-DTI. ii. To determine the therapeutic efficiency of umbilical cord mesenchymal stem cells and also the utility of the integration of BOLD-fMRI and DTI. iii. To correlate the imaging results with the electrophysiology outcomes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date March 2021
Est. primary completion date March 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

1. All tested patients must be Sobriety and coordination the examination.

2. All tested patients with motor nerve fiber damaged must tally with the diagnosis standard which after the head CT, fMRI confirmation and obvious clinical symptoms.

3. Patient's age and gender: 20—65years,the gender is not limit;

4. All patient's must has one side neurological deficits.

5. The patient must receive surgery and stem cell transplantation.

Exclusion Criteria:

1. Progressive dysfunction;

2. Other internal organs strict illness sickness, like serious heart disease, diabetes, liver, kidney vigorous sickness and so on;

3. The patient with tumor in every system on there body;

4. Having the primary or the sequential epilepsy medical history, within one year had the epileptic paroxysm;

5. Can not accept MRI inspection, for some metal implant in there body(such as inner support in heart or brain blood vessel)

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
stem cell transplantation
the motor nerve fiber damaged patient receive a treatment course stem cell transplantation after the hematoma removal.
Procedure:
BOLD-fMRI drived DTI scanning
All patients should be receive cranial BOLD-fMRI drived DTI scanning scanning separately before the transplant and after the transplant 0, 1, 3, 6 and 12 months.

Locations

Country Name City State
China General Hospital of Ningxia Medical University Yinchuan Ningxia
China General Hospital of Ningxia Medical University Yinchuan Ningxia

Sponsors (1)

Lead Sponsor Collaborator
General Hospital of Ningxia Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary BOLD-fMRI drived DTI scanning All patients should be receive cranial BOLD-fMRI drived DTI scanning scanning after the transplant 6 months, and the result tells us that there is obvious reconstruction of motor circuits in nerve fiber on the damaged region; After the transplant 6 months
Secondary FIM All patients should receive the function independence evaluation (FIM) after the transplant 6 months , and the grading has the distinct improvement; after the transplant 6 months
Secondary NIHSS All patients should receive the American State-run Health Research institute apoplexy meter (NIHSS) evaluation after the transplant 6 months , and the grading has the distinct improvement; after the transplant 6 months
Secondary Motor evoked potential All patients should be receive motor evoked potential after the transplant 6 months, and the function of movement and sensation get obvious improvement; after the transplant 6 months